NCT07404683

Brief Summary

This study aims to analyze the effects of an 8-week strength training program combining different exercise intensities and blood flow restriction (BFR) conditions on safety, tolerability, muscle adaptations, and physical performance variables. Three training modalities will be compared: 1) high-intensity exercise with BFR therapy; 2) low-intensity exercise with BFR therapy; and 3) high-intensity exercise without BFR therapy. All groups will perform the same exercise modality, differing only in intensity and the application of BFR. Participants will be randomly assigned to one of the three groups and will undergo a 8-week intervention. The variables of interest will be assessed in each group for subsequent analysis and comparison.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
27mo left

Started Feb 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Feb 2026Sep 2028

Study Start

First participant enrolled

February 1, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

February 2, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 11, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

1.3 years

First QC Date

February 2, 2026

Last Update Submit

February 7, 2026

Conditions

Keywords

blood flow restrictionexercisehigh-intensityrotator cuff

Outcome Measures

Primary Outcomes (6)

  • Isometric rotator cuff strength

    Isometric rotator cuff strength measured with a dynamometer

    Baseline, 4 weeks and 8 weeks

  • Rate of perceived exertion

    Rate of perceived exertion (RPE) measured using the Borg scale (0-10)

    Periprocedural

  • Perceived tolerance

    Participant tolerance to the training protocol will be assessed at the end of the intervention using a 5-point Likert scale, ranging from very well tolerated (5), well tolerated (4), neutral (3), poorly tolerated (2), to very poorly tolerated (1).

    8 weeks

  • Occurrence of adverse effects

    Occurrence of adverse effects (e.g., pain, delayed onset muscle soreness, sudden weakness of the trained limb, redness or swelling of the trained limb, etc.) by self-report

    Immediately after the intervention, 1 hour, 6 hours, 24 hours, 1 week

  • Surface electromyography

    Surface electromyography for the study of muscle recruitment (middle deltoid, infraspinatus, teres minor and trapezius muscles)

    Periprocedural

  • Muscle Thickness

    Muscle thickness of the deltoid, biceps brachii, triceps brachii, and pectoralis major will be assessed using ultrasound imaging

    Baseline, 4 weeks, 8 weeks

Study Arms (3)

High-intensity exercise with blood occlusion

EXPERIMENTAL

Sixteen sessions of exercise during 8 weeks, 70% repetition maximum, and 50% blood occlusion

Device: High-intensity exercise with BFR

Low-intensity exercise with blood occlusion

ACTIVE COMPARATOR

Sixteen sessions of exercise during 8 weeks, 30% repetition maximum, and 50% blood occlusion

Device: Low-intensity exercise with BFR

High-intensity exercise without blood occlusion

ACTIVE COMPARATOR

Sixteen sessions of exercise during 8 weeks, 70% repetition maximum, without blood occlusion

Procedure: High-intensity exercise without BFR

Interventions

Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 70% RM and a without flow restriction application (cuff applied without pressure). 30" rest between sets, 2' rest between exercises.

High-intensity exercise without blood occlusion

Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 70% RM and a 50% of arterial occlusion pressure. 30" rest between sets, 2' rest between exercises.

High-intensity exercise with blood occlusion

Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 30% RM and a 50% of arterial occlusion pressure. 30" rest between sets, 2' rest between exercises.

Low-intensity exercise with blood occlusion

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy, untrained adults
  • Age between 18 and 65

You may not qualify if:

  • Current participation in an upper limb strength training program
  • Presence of comorbidities that increase cardiovascular risk (uncontrolled ischemic heart disease, uncontrolled hypertension, diabetes, etc.)
  • Patients with more than one thromboembolism risk factor (obesity, history of thrombosis, prolonged immobilization, recent surgery, use of contraceptives, etc.)
  • Current diagnosis of any pathology affecting the cervical spine, shoulder, and/or thoracic spine
  • History of surgery in the last year
  • Use of ergogenic aids or medications that affect muscle metabolism (anabolic steroids, testosterone, creatine, protein supplements, corticosteroids, chronic use of nonsteroidal anti-inflammatory drugs, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Adrian Escriche-Escuder, PhD

    University of Valencia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Adrian Escriche-Escuder, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

February 2, 2026

First Posted

February 11, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

February 11, 2026

Record last verified: 2026-02